Ruihong Zeng
Zhongshan East Road 361
Shijiazhuang, 050017, China
Shijiazhuang, 050017, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
CD11c+CD69+ trained APCs in lungs mediate allergic asthma through increased H3K27ac.
Journal: International immunopharmacology
Published: April 24, 2025
Neuropilin-1high monocytes protect against neonatal inflammation.
Journal: Cellular & molecular immunology
Published: September 15, 2023
Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
Journal: Journal of virology
Published: February 13, 2023
Proline metabolism reprogramming of trained macrophages induced by early respiratory infection combined with allergen sensitization contributes to development of allergic asthma in childhood of mice.
Journal: Frontiers in immunology
Published: June 27, 2022
RSV recombinant candidate vaccine G1F/M2 with CpG as an adjuvant prevents vaccine-associated lung inflammation, which may be associated with the appropriate types of immune memory in spleens and lungs.
Journal: Human vaccines & immunotherapeutics
Published: April 26, 2019
Respiratory Syncytial Virus Replication Is Promoted by Autophagy-Mediated Inhibition of Apoptosis.
Journal: Journal of virology
Published: December 21, 2017
Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.
Journal: Journal of virology
Published: February 04, 2012
Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines.
Journal: Virus research
Published: December 02, 2011
A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Journal: Antiviral research
Published: January 09, 2009
Protective effect of a RSV subunit vaccine candidate G1F/M2 was enhanced by a HSP70-Like protein in mice.
Journal: Biochemical and biophysical research communications
Published: September 22, 2008
Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
Journal: Vaccine
Published: May 19, 2007
Showing 1-12 of 12
Last Updated: 09/26/2026